Bioengineering tools for the production of pharmaceuticals: current perspective and future outlook

Abstract

The bioengineering tools have significant advantages through less time-consuming and utilized as a promising stage for the production of pharmaceutical bioproducts under the single platform. This review highlighted the advantages and current improvement in the plant, animal and microbial bioengineering tools and outlines feasible approaches by biological and process's bioengineering levels for advancing the economic feasibility of pharmaceutical's production. The critical analysis results revealed that system biology and synthetic biology along with advanced bioengineering tools like transcriptome, proteome, metabolome and nano bioengineering tools have shown a promising impact on the development of pharmaceutical's bioproducts. Tools to overcome and resolve the accompanying encounters of pharmaceutical's production that include nano bioengineering tools are also discussed. As a summary and prospect, it also gives new insight into the challenges and possible breakthrough of the development of pharmaceutical's bioproducts through bioengineering tools.

RETRACTED ARTICLE: Metagenomics for taxonomy profiling: tools and approaches

“…The development of sophisticated molecular approaches in conjunction with computational regulations has resulted in a decline in the sequencing of aggregate genome DNA and several opportunities related to marine microbial exploration ( Figure 5). As a result, an entire era of metagenomic sequencing has contributed to more in-depth considerations of representing a wider range of species from varying tests [63][64][65][66]. Li et al [67] showed that metagenomicsbased population analyses can provide both community and valuable information without an upgrade slant.…”

New Insights into Detection of a Dendrobine Compound From a Novel Endophytic Trichoderma longibrachiatum Strain and Its Toxicity Against Phytopathogenic Bacteria

“…Owing to the increasing global demand for anti-cancer drugs, the global market for dendrobine is increasing rapidly and is expected to cross the outer limit of other drugs. Thus, the demand for dendrobine will continue to increase (Li et al, 2017;Sarsaiya et al, 2019c). However, dendrobine is an expensive drug and, therefore, not easily accessible to many people worldwide.…”

Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment

“…In addition to the quality assurance, it is necessary to demonstrate batch-by-batch reproducibility in bioprocesses. The production of anti-SARS-CoV-2 mAbs in CHO cells can be seen as a feasible strategy for implementation on an industrial scale in conjunction with high-density cultures [ 272 ], single-use technologies [ 267 ], design/selection techniques for highly productive clones [ 264 , 281 ], and bioprocess optimization [ 266 ]. To achieve this, it is necessary that companies with large biotechnological developments provide insights to the bio-pharmacological industry to combat this global pandemic.…”